SyntekaBio, Inc. (KOSDAQ: 226330)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,490.00
+360.00 (7.02%)
Dec 30, 2024, 1:41 PM KST

SyntekaBio Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
122.33123.41243.99316.66609.68
Revenue Growth (YoY)
170.78%-49.42%-22.95%-48.06%-
Cost of Revenue
2.82.4810.9615.2425.84
Gross Profit
119.53120.92233.04301.42583.84
Selling, General & Admin
8,5477,4777,4564,8284,418
Research & Development
2,8503,2253,1773,1012,108
Other Operating Expenses
216.34187.25149.85106.2498.17
Operating Expenses
13,61412,39712,0259,1937,681
Operating Income
-13,494-12,276-11,792-8,891-7,097
Interest Expense
-1,672-375.74-1,251-254.17-84.36
Interest & Investment Income
563.831,171971.76374.41690.86
Currency Exchange Gain (Loss)
-2.73-0.352.590.22-
Other Non Operating Income (Expenses)
-1,159758.77,583-6,0322.73
EBT Excluding Unusual Items
-15,764-10,723-4,486-14,803-6,488
Gain (Loss) on Sale of Assets
-5.73-0.13-0.15
Asset Writedown
-4.79-72-20.25--
Other Unusual Items
-603.08-603.08---
Pretax Income
-16,377-11,398-4,506-14,803-6,488
Net Income
-16,377-11,398-4,506-14,803-6,488
Net Income to Common
-16,377-11,398-4,506-14,803-6,488
Shares Outstanding (Basic)
1514141313
Shares Outstanding (Diluted)
1514141313
Shares Change (YoY)
8.34%5.94%0.37%1.65%-
EPS (Basic)
-1073.93-796.14-333.47-1099.43-489.80
EPS (Diluted)
-1074.48-796.14-333.47-1099.43-490.00
Free Cash Flow
-18,253-17,442-16,899-13,520-5,457
Free Cash Flow Per Share
-1196.92-1218.35-1250.52-1004.13-411.97
Gross Margin
97.71%97.99%95.51%95.19%95.76%
Operating Margin
-11030.76%-9947.91%-4832.99%-2807.83%-1164.08%
Profit Margin
-13387.52%-9235.91%-1846.96%-4674.69%-1064.13%
Free Cash Flow Margin
-14920.77%-14133.89%-6926.24%-4269.46%-895.05%
EBITDA
-11,220-10,514-10,319-7,733-6,040
D&A For EBITDA
2,2741,7621,4731,1581,058
EBIT
-13,494-12,276-11,792-8,891-7,097
Advertising Expenses
----6
Source: S&P Capital IQ. Standard template. Financial Sources.